Recombinant Mouse LIFR Protein , His

LIFR (Leukemia Inhibitory Factor Receptor) is a key component of the signaling pathway activated by leukemia inhibitory factor (LIF), a cytokine associated with various biological processes, including stem cell maintenance, differentiation, and inflammation. The role of LIFR in these processes has drawn significant interest in the fields of developmental biology and regenerative medicine. Moreover, LIFR has been implicated in several pathological conditions, including cancer and autoimmune diseases, making it a potential target for therapeutic interventions. Research has focused on the characterization of LIFR in both normal and diseased states, revealing its importance in cellular responses to LIF and its potential implications in cell signaling pathways that regulate cell fate. Furthermore, the recombinant expression of LIFR allows for detailed studies of its functional properties and interaction with other molecules. By producing LIFR in a controlled environment, researchers can explore the receptor’s structural characteristics, assess ligand-binding dynamics, and evaluate downstream signaling effects. Understanding LIFR's mechanism of action could lead to novel strategies for manipulating stem cell behavior and developing new treatments for diseases associated with dysregulated LIFR signaling. Thus, ongoing research into LIFR and its recombinant protein forms is crucial for advancing our knowledge of cell signaling and its applications in biotechnology and medicine.